Active Surveillance for Limited GGNs
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorFudan University
About this trial
This study is a single-arm, multi-center, phase III trial conducted under the Eastern Cooperative Thoracic Oncoloy Project (ECTOP) . The primary objective of the study is to assess the 5-year overall survival of patients with one or two ground-glass opacities by employing an active surveillance approach rather than immediate surgical resection.
Eligibility criteria
Qualifiers
Presence of one or two GGNs (bilateral lesions are permitted).
All lesions have remained stable without regression or enlargement for at least 3 months.
The dominant lesion (the lesion with the largest maximum tumor diameter) has a maximum tumor diameter ≥0.6cm and ≤2cm.
CTR ≤0.25 in lesions.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Active surveillance
Treatment groups
387 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov